192 related articles for article (PubMed ID: 30575949)
41. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
[TBL] [Abstract][Full Text] [Related]
42. Nonsteroidal anti-inflammatory drugs and risk of lung cancer.
Hernández-Díaz S; García Rodríguez LA
Int J Cancer; 2007 Apr; 120(7):1565-72. PubMed ID: 17205530
[TBL] [Abstract][Full Text] [Related]
43. Low-dose acetylsalicylic acid for cancer prevention considering risk factors: a retrospective cohort study.
Florensa D; Mateo J; Solsona F; Galván L; Mesas M; Piñol R; Espinosa-Leal L; Godoy P
Ann Epidemiol; 2023 Aug; 84():60-66. PubMed ID: 37302674
[TBL] [Abstract][Full Text] [Related]
44. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.
Siu CW; Lip GY; Lam KF; Tse HF
Heart Rhythm; 2014 Aug; 11(8):1401-8. PubMed ID: 24747420
[TBL] [Abstract][Full Text] [Related]
45. Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study.
Sundström J; Hedberg J; Thuresson M; Aarskog P; Johannesen KM; Oldgren J
Circulation; 2017 Sep; 136(13):1183-1192. PubMed ID: 28947478
[TBL] [Abstract][Full Text] [Related]
46. Aspirin and the risk of nondigestive tract cancers: An updated meta-analysis to 2019.
Santucci C; Gallus S; Martinetti M; La Vecchia C; Bosetti C
Int J Cancer; 2021 Mar; 148(6):1372-1382. PubMed ID: 32984948
[TBL] [Abstract][Full Text] [Related]
47. Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population?
Bermingham M; Shanahan MK; O'Connell E; Dawkins I; Miwa S; O'Hanlon R; Gilmer J; McDonald K; Ledwidge M
Circ Heart Fail; 2014 Mar; 7(2):243-50. PubMed ID: 24493706
[TBL] [Abstract][Full Text] [Related]
48. Regular analgesic use and risk of multiple myeloma.
Moysich KB; Bonner MR; Beehler GP; Marshall JR; Menezes RJ; Baker JA; Weiss JR; Chanan-Khan A
Leuk Res; 2007 Apr; 31(4):547-51. PubMed ID: 16962170
[TBL] [Abstract][Full Text] [Related]
49. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
[TBL] [Abstract][Full Text] [Related]
50. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
[TBL] [Abstract][Full Text] [Related]
51. Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.
Lu L; Shi L; Zeng J; Wen Z
Oncotarget; 2017 Jun; 8(25):40389-40401. PubMed ID: 28418881
[TBL] [Abstract][Full Text] [Related]
52. Daily aspirin use and cancer mortality in a large US cohort.
Jacobs EJ; Newton CC; Gapstur SM; Thun MJ
J Natl Cancer Inst; 2012 Aug; 104(16):1208-17. PubMed ID: 22888140
[TBL] [Abstract][Full Text] [Related]
53. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
55. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
[TBL] [Abstract][Full Text] [Related]
56. A prospective study of aspirin use and the risk for colorectal adenoma.
Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
[TBL] [Abstract][Full Text] [Related]
57. Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.
Genkinger JM; De Vivo I; Stampfer MJ; Giovannucci E; Michaud DS
Int J Cancer; 2007 May; 120(10):2221-5. PubMed ID: 17290403
[TBL] [Abstract][Full Text] [Related]
58. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
[TBL] [Abstract][Full Text] [Related]
59. Functional Independence Measure (WeeFIM) for Chinese children: Hong Kong Cohort.
Wong V; Wong S; Chan K; Wong W
Pediatrics; 2002 Feb; 109(2):E36. PubMed ID: 11826246
[TBL] [Abstract][Full Text] [Related]
60. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW; Anderson KE; Lazovich D; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
